TET2 antibody (AA 1833-2002)
Quick Overview for TET2 antibody (AA 1833-2002) (ABIN6149017)
Target
See all TET2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1833-2002
-
Sequence
- VQGVASGAED NDEVWSDSEQ SFLDPDIGGV AVAPTHGSIL IECAKRELHA TTPLKNPNRN HPTRISLVFY QHKSMNEPKH GLALWEAKMA EKAREKEEEC EKYGPDYVPQ KSHGKKVKRE PAEPHETSEP TYLRFIKSLA ERTMSVTTDS TVTTSPYAFT RVTGPYNRYI
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1833-2002 of human TET2 (NP_001120680.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
-
: "Ascorbic acid induces global epigenetic reprogramming to promote meiotic maturation and developmental competence of porcine oocytes." in: Scientific reports, Vol. 8, Issue 1, pp. 6132, (2018) (PubMed).
-
-
- TET2 (Tet Methylcytosine Dioxygenase 2 (TET2))
-
Alternative Name
- TET2
-
Background
- The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene.,MDS,KIAA1546,TET2,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,DNA Demethylation,TET2
-
Molecular Weight
- 130 kDa/133 kDa/223 kDa
-
Gene ID
- 54790
-
UniProt
- Q6N021
-
Pathways
- Warburg Effect
Target
-